Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-24 @ 2:39 PM
NCT ID:
NCT00038259
Eligibility Criteria:
Note: ACTG A5132 closed to accrual on 11/01/04.
Inclusion Criteria:
* HIV infected
* CD4 cell count of 300 cells/mm3 or more within 30 days prior to study entry
* HIV viral load of less than 50 copies/ml within 30 days prior to study entry
* Anti-HIV drug regimen of at least 3 anti-HIV drugs for at least 6 months immediately prior to study entry
* Documented pretherapy plasma HIV viral load measured within 6 months of starting ART
* Willing to use acceptable methods of contraception
Exclusion Criteria:
* HIV viral load of 50 copies/ml or more within 60 days before study entry
* Current use of experimental anti-HIV drugs other than FDA sanctioned investigational drugs
* Abacavir as part of anti-HIV regimen within 8 weeks prior to study entry
* Pregnant or breastfeeding
* History of autoimmune disease, except for stable autoimmune thyroid disease
* Heart problems or on certain medications for treatment of heart problems
* Cancer requiring chemotherapy
* Untreated thyroid disease
* Disease of the central nervous system that has been active within 1 year prior to study entry
* Uncontrolled diabetes
* Allergies to the study medications
* Other illnesses that would make it inappropriate for patients to participate in the study
* Immunomodulatory therapy within 4 weeks prior to study entry
* Hydroxyurea within 6 months prior to study entry
* Drug or alcohol use that, in the opinion of the investigator, would interfere with the study
* Psychiatric or mental impairment that would affect compliance
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00038259
Study Brief:
Protocol Section:
NCT00038259